VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation
Status:
Completed
Trial end date:
2021-06-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether inhaled epoprostenol given via a breath
actuated delivery system will help improve oxygen levels and treatment outcomes in patients
with COVID-19 who are on mechanical ventilation.